Diabetes

Diabetes

• 

  France: Drugmaker on trial, suspected in deaths

  The makers of a diabetes and weight loss drug suspected in the deaths of hundreds of people went on trial Tuesday, facing charges they misled the ... 

• 

  Generic competition cuts Merck's Q1 sales, profit

  Merck & Co. on Wednesday posted disappointing first-quarter results and cut its earnings forecast for the year. But the world's third-largest ... 

• 

  Newfound hormone holds hope for diabetes treatment

  Scientists have identified a hormone that can sharply boost the number of cells that make insulin in mice, a discovery that may someday lead to a ... 

• 

  J&J 1Q profit falls 10 pct despite higher sales

  Johnson & Johnson's first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and ... 

• FDA reviewing heart risks of Glaxo diabetes pill

  The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was ... 

• 

  Walgreen clinics expand care into chronic illness

  Walgreen Co. has stretched the reach of its drugstore clinics beyond treating ankle sprains and sinus infections to handling chronic diseases such as ... 

• FDA OKs first-of-its-kind diabetes drug from J&J

  The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood ... 

• FDA probes new pancreas risks with diabetes drugs

  The Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of ... 

• 

  Do more women need diabetes care when pregnant?

  A change in testing could nearly triple the number of women diagnosed with diabetes during pregnancy, but would catching milder cases help mother or ... 

• Novo Nordisk US shares skid on drug review setback

  Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two ... 

• Novo Nordisk says FDA rejects insulin drugs

  Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes. 

• 

  Poll: Few Americans know all the risks of obesity

  Heart disease and diabetes get all the attention, but what about the many other ways obesity can damage your health? Carrying too many pounds may lead ... 

• 

  APNewsBreak: Sotomayor book offers personal look

  Supreme Court Justice Sonia Sotomayor says in her upcoming memoir that her lifelong battle against diabetes and the fear that she might die early ...